Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 52

1.

Causes and Risk Factors of Cerebral Ischemic Events in Patients With Atrial Fibrillation Treated With Non-Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention.

Paciaroni M, Agnelli G, Caso V, Silvestrelli G, Seiffge DJ, Engelter S, De Marchis GM, Polymeris A, Zedde ML, Yaghi S, Michel P, Eskandari A, Antonenko K, Sohn SI, Cappellari M, Tassinari T, Tassi R, Masotti L, Katsanos AH, Giannopoulos S, Acciarresi M, Alberti A, Venti M, Mosconi MG, Vedovati MC, Pierini P, Giustozzi M, Lotti EM, Ntaios G, Kargiotis O, Monaco S, Lochner P, Bandini F, Liantinioti C, Palaiodimou L, Abdul-Rahim AH, Lees K, Mancuso M, Pantoni L, Rosa S, Bertora P, Galliazzo S, Ageno W, Toso E, Angelini F, Chiti A, Orlandi G, Denti L, Flomin Y, Marcheselli S, Mumoli N, Rimoldi A, Verrengia E, Schirinzi E, Del Sette M, Papamichalis P, Komnos A, Popovic N, Zarkov M, Rocco A, Diomedi M, Giorli E, Ciccone A, Mac Grory BC, Furie KL, Bonetti B, Saia V, Guideri F, Acampa M, Martini G, Grifoni E, Padroni M, Karagkiozi E, Perlepe K, Makaritsis K, Mannino M, Maccarrone M, Ulivi L, Giannini N, Ferrari E, Pezzini A, Doronin B, Volodina V, Baldi A, D'Amore C, Deleu D, Corea F, Putaala J, Santalucia P, Nardi K, Risitano A, Toni D, Tsivgoulis G.

Stroke. 2019 Aug;50(8):2168-2174. doi: 10.1161/STROKEAHA.119.025350. Epub 2019 Jun 25.

PMID:
31234756
2.

Direct Oral Anticoagulants in Patients Undergoing Urgent Reperfusion for Nonvalvular Atrial Fibrillation-Related Ischemic Stroke: A Brief Report on Literature Evidence.

Masotti L, Grifoni E, Dei A, Vannucchi V, Moroni F, Panigada G, Nicotra C, Spolveri S, Landini G.

Neurol Res Int. 2019 Feb 24;2019:9657073. doi: 10.1155/2019/9657073. eCollection 2019. Review.

3.

Microscopic description of acid-base equilibrium.

Grifoni E, Piccini G, Parrinello M.

Proc Natl Acad Sci U S A. 2019 Feb 14. pii: 201819771. doi: 10.1073/pnas.1819771116. [Epub ahead of print]

PMID:
30765522
4.

Direct oral anticoagulants in the early phase of non valvular atrial fibrillation-related acute ischemic stroke: focus on real life studies.

Masotti L, Grifoni E, Dei A, Vannucchi V, Moroni F, Panigada G, Spolveri S, Landini G.

J Thromb Thrombolysis. 2019 Feb;47(2):292-300. doi: 10.1007/s11239-018-1775-2. Review.

PMID:
30470967
5.

Ninety-day prognosis of patients receiving direct oral anticoagulants in the early phase of non valvular atrial fibrillation-related acute ischemic stroke: The real life evidence.

Masotti L, Grifoni E, Dei A, Vannucchi V, Moroni F, Spolveri S, Panigada G, Landini G.

Thromb Res. 2018 Dec;172:165-168. doi: 10.1016/j.thromres.2018.11.004. Epub 2018 Nov 3. No abstract available.

PMID:
30419471
6.

Risk of reoperation in bioprosthetic valve patients with indication for long-term anticoagulation. Results from the observational retrospective multicentre PLECTRUM study.

Poli D, Antonucci E, Pengo V, Grifoni E, Maggini N, Testa S, Lodigiani C, Insana A, Marongiu F, Barcellona D, Paparo C, Bucherini E, Pignatelli P, Palareti G.

Open Heart. 2018 Aug 27;5(2):e000837. doi: 10.1136/openhrt-2018-000837. eCollection 2018.

7.

Direct oral anticoagulants in the early phase of non-valvular atrial fibrillation-related ischemic stroke in very old patients undergoing systemic thrombolysis and/or mechanical thrombectomy.

Masotti L, Moroni F, Vannucchi V, Grifoni E, Dei A, Landini G.

Geriatr Gerontol Int. 2018 Aug;18(8):1304-1305. doi: 10.1111/ggi.13453. No abstract available.

PMID:
30136389
8.

On-Treatment Platelet Reactivity is a Predictor of Adverse Events in Peripheral Artery Disease Patients Undergoing Percutaneous Angioplasty.

Grifoni E, Gori AM, Giusti B, Valenti R, Migliorini A, Basili S, Paniccia R, Elmahdy MF, Pulli R, Pratesi C, Antoniucci D, Violi F, Marcucci R.

Eur J Vasc Endovasc Surg. 2018 Oct;56(4):545-552. doi: 10.1016/j.ejvs.2018.06.032. Epub 2018 Jul 17.

PMID:
30025662
9.

Incidence of bleeding in patients with atrial fibrillation and advanced liver fibrosis on treatment with vitamin K or non-vitamin K antagonist oral anticoagulants.

Pastori D, Lip GYH, Farcomeni A, Del Sole F, Sciacqua A, Perticone F, Marcucci R, Grifoni E, Pignatelli P, Violi F; ATHERO-AF study group.

Int J Cardiol. 2018 Aug 1;264:58-63. doi: 10.1016/j.ijcard.2018.01.097.

PMID:
29776574
10.

Data on incidence of bleeding in patients with atrial fibrillation and advanced liver fibrosis on treatment with vitamin K or non-vitamin K antagonist oral anticoagulants.

Pastori D, Lip GYH, Farcomeni A, Del Sole F, Sciacqua A, Perticone F, Marcucci R, Grifoni E, Pignatelli P, Violi F; ATHERO-AF study group.

Data Brief. 2018 Feb 6;17:830-836. doi: 10.1016/j.dib.2018.01.109. eCollection 2018 Apr.

11.

Breast cancer: effectiveness of a one-year unsupervised exercise program.

Mascherini G, Tosi B, Giannelli C, Grifoni E, Degl'innocenti S, Galanti G.

J Sports Med Phys Fitness. 2019 Feb;59(2):283-289. doi: 10.23736/S0022-4707.18.08131-8. Epub 2018 Mar 1.

PMID:
29498250
12.

Confidence in the Use of Direct Oral Anticoagulants in the Acute Phase of Nonvalvular Atrial Fibrillation-Related Ischemic Stroke Over the Years: A Real-World Single-Center Study.

Moroni F, Masotti L, Vannucchi V, Chiarelli R, Seravalle C, Pesci A, Pallini F, Puliti S, Cimolato B, Fattorini L, Scerra C, Ristori F, Imbalzano ML, Spolveri S, Landini G, Grifoni E, Paciaroni M.

J Stroke Cerebrovasc Dis. 2018 Jan;27(1):76-82. doi: 10.1016/j.jstrokecerebrovasdis.2017.08.001. Epub 2017 Sep 13.

PMID:
28918086
13.

Micro-Laser-Induced Breakdown Spectroscopy (Micro-LIBS) Study on Ancient Roman Mortars.

Pagnotta S, Lezzerini M, Ripoll-Seguer L, Hidalgo M, Grifoni E, Legnaioli S, Lorenzetti G, Poggialini F, Palleschi V.

Appl Spectrosc. 2017 Apr;71(4):721-727. doi: 10.1177/0003702817695289. Epub 2017 Mar 21.

PMID:
28374609
14.

Erythrocyte oxidative stress is associated with cell deformability in patients with retinal vein occlusion.

Becatti M, Marcucci R, Gori AM, Mannini L, Grifoni E, Alessandrello Liotta A, Sodi A, Tartaro R, Taddei N, Rizzo S, Prisco D, Abbate R, Fiorillo C.

J Thromb Haemost. 2016 Nov;14(11):2287-2297. doi: 10.1111/jth.13482. Epub 2016 Oct 11.

15.

Liver dysfunction as predictor of prognosis in patients with amyloidosis: utility of the Model for End-stage Liver disease (MELD) scoring system.

Cappelli F, Baldasseroni S, Bergesio F, Spini V, Fabbri A, Angelotti P, Grifoni E, Attanà P, Tarantini F, Marchionni N, Moggi Pignone A, Perfetto F.

Intern Emerg Med. 2017 Feb;12(1):23-30. doi: 10.1007/s11739-016-1500-0. Epub 2016 Aug 1.

PMID:
27480755
16.

Sharing data of clinical trials.

Prisco D, Ciuti G, Grifoni E, Silvestri E, Emmi G.

Eur J Intern Med. 2016 Sep;33:e25-6. doi: 10.1016/j.ejim.2016.05.012. Epub 2016 May 25. No abstract available.

PMID:
27236295
17.

X-Ray Fluorescence Analysis and Self-Organizing Maps Classification of the Etruscan Gold Coin Collection at the Monetiere of Florence.

Arias C, Bani S, Catalli F, Lorenzetti G, Grifoni E, Legnaioli S, Pagnotta S, Palleschi V.

Appl Spectrosc. 2017 May;71(5):817-822. doi: 10.1177/0003702816641421. Epub 2016 May 6.

PMID:
27154737
18.

Searching for a common mechanism for placenta-mediated pregnancy complications and cardiovascular disease: role of lipoprotein(a).

Romagnuolo I, Sticchi E, Attanasio M, Grifoni E, Cioni G, Cellai AP, Abbate R, Fatini C.

Fertil Steril. 2016 May;105(5):1287-1293.e3. doi: 10.1016/j.fertnstert.2016.01.014. Epub 2016 Jan 29.

PMID:
26827667
19.

Different NT-proBNP circulating levels for different types of cardiac amyloidosis.

Perfetto F, Bergesio F, Grifoni E, Fabbri A, Ciuti G, Frusconi S, Angelotti P, Spini V, Cappelli F.

J Cardiovasc Med (Hagerstown). 2016 Nov;17(11):810-7. doi: 10.2459/JCM.0000000000000349.

PMID:
26765991
20.

High on-aspirin platelet reactivity predicts cardiac death in acute coronary syndrome patients undergoing PCI.

Gori AM, Grifoni E, Valenti R, Giusti B, Paniccia R, Parodi G, Migliorini A, Antoniucci D, Abbate R, Gensini GF, Marcucci R.

Eur J Intern Med. 2016 May;30:49-54. doi: 10.1016/j.ejim.2015.12.003. Epub 2016 Jan 5. No abstract available.

PMID:
26764084
21.

On-treatment platelet reactivity: State of the art and perspectives.

Marcucci R, Grifoni E, Giusti B.

Vascul Pharmacol. 2016 Feb;77:8-18. doi: 10.1016/j.vph.2015.10.005. Epub 2015 Oct 28. Review.

PMID:
26520003
22.

The Val142Ile transthyretin cardiac amyloidosis: not only an Afro-American pathogenic variant? A single-centre Italian experience.

Cappelli F, Frusconi S, Bergesio F, Grifoni E, Fabbri A, Giuliani C, Falconi S, Bonifacio S, Perfetto F.

J Cardiovasc Med (Hagerstown). 2016 Feb;17(2):122-5. doi: 10.2459/JCM.0000000000000290.

PMID:
26428663
23.

Non-traumatic splenic rupture on dual antiplatelet therapy with aspirin and ticagrelor after stenting for acute coronary syndrome.

Grifoni E, Paniccia R, Giusti B, Sticchi E, Padeletti L, Cavallini C, Marcucci R.

J Cardiol Cases. 2015 Jun 6;12(3):65-67. doi: 10.1016/j.jccase.2015.05.001. eCollection 2015 Sep.

24.

The Val142Ile transthyretin cardiac amyloidosis: more than an Afro-American pathogenic variant.

Perfetto F, Frusconi S, Bergesio F, Grifoni E, Fabbri A, Giuliani C, Falconi S, Bonifacio S, Cappelli F.

J Community Hosp Intern Med Perspect. 2015 Apr 1;5(2):26931. doi: 10.3402/jchimp.v5.26931. eCollection 2015. No abstract available.

25.

The platypnea-orthodeoxia syndrome: an unusual case of dyspnea.

Fabbri A, Grifoni E, Ciuti G, Perfetto F, Moggi Pignone A.

Intern Emerg Med. 2015 Jun;10(4):535-6. doi: 10.1007/s11739-015-1231-7. Epub 2015 Apr 7. No abstract available.

PMID:
25845439
26.

Echocardiographic and biohumoral characteristics in patients with AL and TTR amyloidosis at diagnosis.

Cappelli F, Baldasseroni S, Bergesio F, Perlini S, Salinaro F, Padeletti L, Attanà P, Paoletti Perini A, Moggi Pignone A, Grifoni E, Fabbri A, Marchionni N, Gensini GF, Perfetto F.

Clin Cardiol. 2015 Feb;38(2):69-75. doi: 10.1002/clc.22353. Epub 2015 Feb 2.

27.

Residual perfusion defects in patients with pulmonary embolism are related to impaired fibrinolytic capacity.

Lami D, Cellai AP, Antonucci E, Fiorillo C, Becatti M, Grifoni E, Cenci C, Marcucci R, Mannini L, Miniati M, Abbate R, Prisco D.

Thromb Res. 2014 Sep;134(3):737-41. doi: 10.1016/j.thromres.2014.07.013. Epub 2014 Jul 17.

PMID:
25074740
28.

Biohumoral markers as predictor of right ventricular dysfunction in AL Amyloidosis.

Cappelli F, Baldasseroni S, Bergesio F, Padeletti L, Attanà P, Pignone AM, Grifoni E, Ciuti G, Fabbri A, Tarantini F, Marchionni N, Gensini GF, Perfetto F.

Amyloid. 2014 Jun;21(2):97-102. doi: 10.3109/13506129.2014.884971. Epub 2014 Feb 11.

PMID:
24517408
29.

Hypokalemia-induced rhabdomyolysis.

Grifoni E, Fabbri A, Ciuti G, Matucci Cerinic M, Moggi Pignone A.

Intern Emerg Med. 2014 Jun;9(4):487-8. doi: 10.1007/s11739-013-1033-8. Epub 2013 Dec 19. No abstract available.

PMID:
24352794
30.

Central nervous system hemangiopericytoma with bone and lung metastases: a case report.

Fabbri A, Grifoni E, Ciuti G, Fedi R, Moggi Pignone A.

Intern Emerg Med. 2014 Apr;9(3):349-50. doi: 10.1007/s11739-013-0975-1. Epub 2013 Jul 3. No abstract available.

PMID:
23820964
31.

A case of persistent hiccup after laparoscopic cholecystectomy.

Grifoni E, Marchiani C, Fabbri A, Ciuti G, Pavellini A, Mancuso F, Viligiardi R, Moggi Pignone A.

Case Rep Surg. 2013;2013:206768. doi: 10.1155/2013/206768. Epub 2013 Apr 4.

32.

Fibrinolytic inhibitors and fibrin characteristics determine a hypofibrinolytic state in patients with pulmonary embolism.

Cellai AP, Lami D, Antonucci E, Fiorillo C, Becatti M, Olimpieri B, Bani D, Grifoni E, Cenci C, Marcucci R, Mannini L, Poli D, Abbate R, Prisco D.

Thromb Haemost. 2013 Mar;109(3):565-7. doi: 10.1160/TH12-09-0648. Epub 2013 Jan 10. No abstract available.

PMID:
23306795
33.

Risk of recurrence in patients with pulmonary embolism: predictive role of D-dimer and of residual perfusion defects on lung scintigraphy.

Poli D, Cenci C, Antonucci E, Grifoni E, Arcangeli C, Prisco D, Abbate R, Miniati M.

Thromb Haemost. 2013 Feb;109(2):181-6. doi: 10.1160/TH12-07-0534. Epub 2012 Nov 29.

PMID:
23196319
34.

Incidence and characteristics of asymptomatic distal deep vein thrombosis unexpectedly found at admission in an Internal Medicine setting.

Ciuti G, Grifoni E, Pavellini A, Righi D, Livi R, Perfetto F, Abbate R, Prisco D, Pignone AM.

Thromb Res. 2012 Oct;130(4):591-5. doi: 10.1016/j.thromres.2012.05.018. Epub 2012 Jun 12.

PMID:
22694877
35.

Long-term outcomes of patients with cerebral vein thrombosis: a multicenter study.

Dentali F, Poli D, Scoditti U, Di Minno MN, De Stefano V, Siragusa S, Kostal M, Palareti G, Sartori MT, Grandone E, Vedovati MC, Ageno W; CErebral VEin Thrombosis International Study Investigators, Falanga A, Lerede T, Bianchi M, Testa S, Witt D, McCool K, Bucherini E, Grifoni E, Coalizzo D, Benedetti R, Marietta M, Sessa M, Guaschino C, di Minno G, Tufano A, Barbar S, Malato A, Pini M, Castellini P, Barco S, Barone M, Paciaroni M, Alberti A, Agnelli G, Giorgi Pierfranceschi M, Dulicek P, Silingardi M, Federica L, Ghirarduzzi A, Tiraferri E, di Lazzaro V, Rossi E, Ciminello A, Pasca S, Barillari G, Rezoagli E, Galli M, Squizzato A, Tosetto A.

J Thromb Haemost. 2012 Jul;10(7):1297-302. doi: 10.1111/j.1538-7836.2012.04774.x. Erratum in: J Thromb Haemost. 2013 Feb;11(2):399. Stefano, V D [corrected to De Stefano, V].

36.

Impact of glomerular filtration estimate on bleeding risk in very old patients treated with vitamin K antagonists. Results of EPICA study on the behalf of FCSA (Italian Federation of Anticoagulation Clinics).

Poli D, Antonucci E, Zanazzi M, Grifoni E, Testa S, Ageno W, Palareti G.

Thromb Haemost. 2012 Jun;107(6):1100-6. doi: 10.1160/TH11-10-0721. Epub 2012 Apr 26.

PMID:
22535516
37.

The thrombophilic pattern of different clinical manifestations of venous thromboembolism: a survey of 443 cases of venous thromboembolism.

Grifoni E, Marcucci R, Ciuti G, Cenci C, Poli D, Mannini L, Liotta AA, Miniati M, Abbate R, Prisco D.

Semin Thromb Hemost. 2012 Mar;38(2):230-4. doi: 10.1055/s-0032-1301420. Epub 2012 Feb 8.

PMID:
22422337
38.

Incidence of thromboembolic complications in patients with atrial fibrillation or mechanical heart valves with a subtherapeutic international normalized ratio: a prospective multicenter cohort study.

Dentali F, Pignatelli P, Malato A, Poli D, Di Minno MN, Di Gennaro L, Rancan E, Pastori D, Grifoni E, Squizzato A, Siragusa S, Di Minno G, Ageno W.

Am J Hematol. 2012 Apr;87(4):384-7. doi: 10.1002/ajh.23119. Epub 2012 Feb 24. Erratum in: Am J Hematol. 2012 Jul;87(7):748. Grifoni, Elena [corrected to Grifoni, Elisa].

39.

Risk of bleeding in low-risk atrial fibrillation patients on warfarin waiting for elective cardioversion.

Poli D, Antonucci E, Grifoni E, Paoletti O, Rancan E, Dentali F, Testa S.

Thromb Res. 2012 May;129(5):588-90. doi: 10.1016/j.thromres.2011.08.031. Epub 2011 Oct 4.

PMID:
21975030
40.

Lack of activation of renal functional reserve predicts the risk of significant renal involvement in systemic sclerosis.

Livi R, Guiducci S, Perfetto F, Ciuti G, Grifoni E, Conforti L, Galluccio F, Moggi Pignone A, Matucci Cerinic M.

Ann Rheum Dis. 2011 Nov;70(11):1963-7. doi: 10.1136/ard.2011.152892. Epub 2011 Jul 21.

PMID:
21784725
41.

Retinal vein occlusions: a review for the internist.

Marcucci R, Sofi F, Grifoni E, Sodi A, Prisco D.

Intern Emerg Med. 2011 Aug;6(4):307-14. doi: 10.1007/s11739-010-0478-2. Epub 2010 Dec 14. Review.

PMID:
21547483
42.
43.

Bleeding and stroke risk in a real-world prospective primary prevention cohort of patients with atrial fibrillation.

Poli D, Testa S, Antonucci E, Grifoni E, Paoletti O, Lip GYH.

Chest. 2011 Oct;140(4):918-924. doi: 10.1378/chest.10-3024. Epub 2011 Apr 21. Erratum in: Chest. 2013 Aug;144(2):721.

44.

Stroke risk stratification in a "real-world" elderly anticoagulated atrial fibrillation population.

Poli D, Lip GY, Antonucci E, Grifoni E, Lane D.

J Cardiovasc Electrophysiol. 2011 Jan;22(1):25-30. doi: 10.1111/j.1540-8167.2010.01858.x.

PMID:
20653814
45.

Incidence of recurrent venous thromboembolism and of chronic thromboembolic pulmonary hypertension in patients after a first episode of pulmonary embolism.

Poli D, Grifoni E, Antonucci E, Arcangeli C, Prisco D, Abbate R, Miniati M.

J Thromb Thrombolysis. 2010 Oct;30(3):294-9. doi: 10.1007/s11239-010-0452-x.

PMID:
20157841
46.

Fibrin resistance to lysis in patients with pulmonary hypertension other than thromboembolic.

Miniati M, Fiorillo C, Becatti M, Monti S, Bottai M, Marini C, Grifoni E, Formichi B, Bauleo C, Arcangeli C, Poli D, Nassi PA, Abbate R, Prisco D.

Am J Respir Crit Care Med. 2010 May 1;181(9):992-6. doi: 10.1164/rccm.200907-1135OC. Epub 2010 Jan 14.

PMID:
20075386
47.

Different models for oral anticoagulation management may be applied provided that minimal assistance criteria are fulfilled: an Italian experience.

Prisco D, Antonucci E, Grifoni E, Mazzaglia G, Bellandi T, Tartaglia R, Poli D.

Semin Thromb Hemost. 2009 Sep;35(6):568-73. doi: 10.1055/s-0029-1240017. Epub 2009 Sep 28.

PMID:
19787561
48.

Bleeding risk during oral anticoagulation in atrial fibrillation patients older than 80 years.

Poli D, Antonucci E, Grifoni E, Abbate R, Gensini GF, Prisco D.

J Am Coll Cardiol. 2009 Sep 8;54(11):999-1002. doi: 10.1016/j.jacc.2009.05.046.

49.

Gender differences in stroke risk of atrial fibrillation patients on oral anticoagulant treatment.

Poli D, Antonucci E, Grifoni E, Abbate R, Gensini GF, Prisco D.

Thromb Haemost. 2009 May;101(5):938-42.

PMID:
19404548
50.

The role of D-dimer testing in patients with suspected venous thromboembolism.

Prisco D, Grifoni E.

Semin Thromb Hemost. 2009 Feb;35(1):50-9. doi: 10.1055/s-0029-1214148. Epub 2009 Mar 23.

PMID:
19308893

Supplemental Content

Loading ...
Support Center